FDA
-
-
-
-
-
-
-
KALA BIO launches commercial AI research platform for biotech
-
-
-
-
-
-
-
KALA BIO Announces Strategic Initiative to Deploy and Continue to Develop an On-Premises AI Infrastructure Platform for the Biotech Industry; Enters Into Platform Development and Exclusive License Agr
-
-
-
-
-
-
-
KALA BIO fails to meet primary endpoint in corneal defect trial
-
-
-
-
-
-
-
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Kala Bio (KALA)
-
-
-
-
-
-
-
KALA BIO Announces $10,750,000 Private Placement
-
-
-
-
-
-
-
Kala Pharmaceuticals (KALA) Announces $12,500,000 Private Placement
-
329,912 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

